1![Microsoft Word - 100741workpaper Microsoft Word - 100741workpaper](https://www.pdfsearch.io/img/680e6bdfff0645e2c9803098390fd7c0.jpg) | Add to Reading ListSource URL: impactaging.comLanguage: English |
---|
2![Microsoft Word - 100741workpaper Microsoft Word - 100741workpaper](https://www.pdfsearch.io/img/8bc9c0cf21e7fa1d29fa929bf5029498.jpg) | Add to Reading ListSource URL: www.impactaging.comLanguage: English |
---|
3![Trastuzumab (Herceptin) Factsheet This factsheet explains what trastuzumab is, how it works, when it may be given, its benefits and the possible side effects. Trastuzumab (Herceptin) Factsheet This factsheet explains what trastuzumab is, how it works, when it may be given, its benefits and the possible side effects.](https://www.pdfsearch.io/img/73f744d78e20ab411e2199b56d6b4410.jpg) | Add to Reading ListSource URL: www2.breastcancercare.org.ukLanguage: English - Date: 2015-03-27 11:51:24
|
---|
4![Oncotype DX / Ribbon symbolism / Breast cancer / Trastuzumab / HER2/neu / Adjuvant therapy / Tamoxifen / Metastatic breast cancer / Predictive marker / Medicine / Cancer treatments / Oncology Oncotype DX / Ribbon symbolism / Breast cancer / Trastuzumab / HER2/neu / Adjuvant therapy / Tamoxifen / Metastatic breast cancer / Predictive marker / Medicine / Cancer treatments / Oncology](/pdf-icon.png) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2015-03-12 00:25:18
|
---|
5![Public Summary Document Application No. 1230 – HER2 ISH testing for access to trastuzumab for neoadjuvant breast cancer Applicant: Roche Products Pty Ltd Australia Date of MSAC consideration: 2 August 2012 Public Summary Document Application No. 1230 – HER2 ISH testing for access to trastuzumab for neoadjuvant breast cancer Applicant: Roche Products Pty Ltd Australia Date of MSAC consideration: 2 August 2012](https://www.pdfsearch.io/img/9dc118867529109668626ca425ca8a7d.jpg) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2014-11-06 23:49:40
|
---|
6![HER2/neu / Biology / Breast cancer / Pharmaceutical Benefits Scheme / Health / Cancer treatments / Predictive marker / Breast cancer chemotherapy / Medicine / Trastuzumab / Ribbon symbolism HER2/neu / Biology / Breast cancer / Pharmaceutical Benefits Scheme / Health / Cancer treatments / Predictive marker / Breast cancer chemotherapy / Medicine / Trastuzumab / Ribbon symbolism](/pdf-icon.png) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2014-11-06 23:49:40
|
---|
7![Public Summary Document Application No. 1230 – HER2 ISH testing for access to trastuzumab for neoadjuvant breast cancer Applicant: Roche Products Pty Ltd Australia Date of MSAC consideration: 2 August 2012 Public Summary Document Application No. 1230 – HER2 ISH testing for access to trastuzumab for neoadjuvant breast cancer Applicant: Roche Products Pty Ltd Australia Date of MSAC consideration: 2 August 2012](https://www.pdfsearch.io/img/d63fc81fb1e6ea670e8b1330e054763b.jpg) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2014-11-06 23:49:41
|
---|
8![HER2/neu / Biology / Breast cancer / Pharmaceutical Benefits Scheme / Health / Cancer treatments / Predictive marker / Breast cancer chemotherapy / Medicine / Trastuzumab / Ribbon symbolism HER2/neu / Biology / Breast cancer / Pharmaceutical Benefits Scheme / Health / Cancer treatments / Predictive marker / Breast cancer chemotherapy / Medicine / Trastuzumab / Ribbon symbolism](/pdf-icon.png) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2014-11-06 23:49:40
|
---|
9![Microsoft Word - Ratified Short Minutes - MSAC 56th Meeting (2 Aug[removed]doc Microsoft Word - Ratified Short Minutes - MSAC 56th Meeting (2 Aug[removed]doc](https://www.pdfsearch.io/img/f683a7ab8a0880de4f4c5d38103eaa36.jpg) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2014-11-06 23:49:42
|
---|
10![Trastuzumab / HER2/neu / Biology / Breast cancer / Management of cancer / Predictive marker / Breast cancer chemotherapy / Ribbon symbolism / Medicine / Cancer treatments Trastuzumab / HER2/neu / Biology / Breast cancer / Management of cancer / Predictive marker / Breast cancer chemotherapy / Ribbon symbolism / Medicine / Cancer treatments](/pdf-icon.png) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2014-11-06 23:49:40
|
---|